Glypican 3 expression in tumors with loss of SMARCB1/INI1 protein expression

Human Pathology

Volumn 44, Issue 4, 2013, Pages 526-533

  Kohashi, Kenichi ^a   Nakatsura, Tetsuya ^b   Kinoshita, Yoshiaki ^a   Yamamoto, Hidetaka ^a   Yamada, Yuichi ^a   Tajiri, Tatsuro ^c   Taguchi, Tomoaki ^a   Iwamoto, Yukihide ^a   Oda, Yoshinao ^a  

^a KYUSHU UNIVERSITY   (Japan)

^b NATIONAL CANCER CENTER HOSPITAL EAST   (Japan)

^c KYOTO PREFECTURAL UNIVERSITY OF MEDICINE   (Japan)

Author keywords

Glypican 3; Malignant rhabdoid tumor; SMARCB1 INI1

Indexed keywords

GLYPICAN 3; INI1 PROTEIN; MESSENGER RNA; PROTEIN; UNCLASSIFIED DRUG;

ARTICLE; BONE TUMOR; CANCER IMMUNOTHERAPY; CANCER PROGNOSIS; CHILD; CONTROLLED STUDY; DIFFERENTIAL DIAGNOSIS; ENZYME LINKED IMMUNOSORBENT ASSAY; EPITHELIOID SARCOMA; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; INFANT; MAJOR CLINICAL STUDY; MALE; MALIGNANT NEOPLASTIC DISEASE; MALIGNANT RHABDOID TUMOR; NEPHROBLASTOMA; PRESCHOOL CHILD; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RHABDOID TUMOR; SCHOOL CHILD; SOFT TISSUE TUMOR; TUMOR CELL;

CHILD; CHILD, PRESCHOOL; CHROMOSOMAL PROTEINS, NON-HISTONE; DIAGNOSIS, DIFFERENTIAL; DNA-BINDING PROTEINS; FEMALE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, NEOPLASTIC; GLYPICANS; HUMANS; IMMUNOENZYME TECHNIQUES; INFANT; INFANT, NEWBORN; MALE; RHABDOID TUMOR; RNA, MESSENGER; SARCOMA; SOFT TISSUE NEOPLASMS; TRANSCRIPTION FACTORS; TUMOR MARKERS, BIOLOGICAL;

EID: 84875224097     PISSN: 00468177     EISSN: 15328392     Source Type: Journal    
DOI: 10.1016/j.humpath.2012.06.014     Document Type: Article

References (26)

1. D. Maeda, S. Ota, and Y. Takazawa Glypican-3 expression in clear cell adenocarcinoma of the ovary Mod Pathol 22 2009 824 832
2. Y.K. Sung, S.Y. Hwang, and M.K. Park Glypican-3 is overexpressed in human hepatocellular carcinoma Cancer Sci 94 2003 259 262
3. D.L. Zynger, N.D. Dimov, C. Luan, B.T. Teh, and X.J. Yang Glypican 3: a novel marker in testicular germ cell tumors Am J Surg Pathol 30 2006 1570 1575
4. G. Pilia, R.M. Hughes-Benzie, and A. MacKenzie Mutations in GPC3, a glypican gene, cause the Simpson-Golabi-Behmel overgrowth syndrome Nat Genet 12 1996 241 247
5. J.B. Beckwith, and N.F. Palmer Histopathology and prognosis of Wilms tumors: results from the First National Wilms' Tumor Study Cancer 41 1978 1937 1948
6. M. Hasselblatt, S. Gesk, and F. Oyen Nonsense mutation and inactivation of SMARCA4 (BRG1) in an atypical teratoid/rhabdoid tumor showing retained SMARCB1 (INI1) expression Am J Surg Pathol 35 2011 933 935
7. K. Kohashi, Y. Oda, and H. Yamamoto Highly aggressive behavior of malignant rhabdoid tumor: a special reference to SMARCB1/INI1 gene alterations using molecular genetic analysis including quantitative real-time PCR J Cancer Res Clin Oncol 133 2007 817 824
8. Y. Oda, and M. Tsuneyoshi Extrarenal rhabdoid tumors of soft tissue: clinicopathological and molecular genetic review and distinction from other soft-tissue sarcomas with rhabdoid features Pathol Int 56 2006 287 295
9. L. Chbani, L. Guillou, and P. Terrier Epithelioid sarcoma: a clinicopathologic and immunohistochemical analysis of 106 cases from the French sarcoma group Am J Clin Pathol 131 2009 222 227
10. T.J. Hollmann, and J.L. Hornick INI1-deficient tumors: diagnostic features and molecular genetics Am J Surg Pathol 35 2011 e47 e63
11. J.L. Hornick, P. Dal Cin, and C.D.M. Fletcher Loss of INI1 expression in characteristic of both conventional and proximal-type epithelioid sarcoma Am J Surg Pathol 33 2009 542 550
12. K. Kohashi, T. Izumi, and Y. Oda Infrequent SMARCB1/INI1 gene alteration in epithelioid sarcoma: a useful tool in distinguishing epithelioid sarcoma from malignant rhabdoid tumor Hum Pathol 40 2009 349 355
13. K. Kohashi, Y. Oda, and H. Yamamoto SMARCB1/INI1 protein expression in round cell soft tissue sarcomas associated with chromosomal translocations involving EWS: a special reference to SMARCB1/INI1 negative variant extraskeletal myxoid chondrosarcoma Am J Surg Pathol 32 2008 1168 1174
14. L. Guillou, and Y. Kaneko Epithelioid sarcoma C.D.M. Fletcher, K.K. Unni, F. Mertens, World Health Organization Classification of Tumours: Pathology and Genetics of Tumours of Soft Tissue and Bone 2002 IARG Press Lyon, France 205 207
15. D.R. Lucas, and S. Heim Extraskeletal myxoid chondrosarcoma C.D.M. Fletcher, K.K. Unni, F. Mertens, World Health Organization Classification of Tumours: Pathology and Genetics of Tumours of Soft Tissue and Bone 2002 IARG Press Lyon, France 213 215
16. D. Schofield Extrarenal rhabdoid tumour C.D.M. Fletcher, K.K. Unni, F. Mertens, World Health Organization Classification of Tumours: Pathology and Genetics of Tumours of Soft Tissue and Bone 2002 IARG Press Lyon, France 219 220
17. G.R. Somers, A.A. Gupta, and A.S. Doria Pediatric undifferentiated sarcoma of the soft tissues: a clinicopathologic study Pediatr Dev Pathol 9 2006 132 142
18. P.A. Kreiger, A.R. Judkins, P.A. Russo, J.A. Biegel, B.J. Lestini, and C. Assanasen Loss of INI1 expression defines a unique subset of pediatric undifferentiated soft tissue sarcomas Mod Pathol 22 2009 142 150
19. T. Nakatsura, T. Kageshita, and S. Ito Identification of glypican-3 as a novel tumor marker for melanoma Clin Cancer Res 10 2004 6612 6621
20. T. Nakatsura, and Y. Nishimura Usefulness of the novel oncofetal antigen glypican-3 for diagnosis of hepatocellular carcinoma and melanoma BioDrugs 19 2005 71 77
21. T. Nakatsura, Y. Yoshitake, and S. Senju Glypican-3, overexpressed specifically in human hepatocellular carcinoma, is a novel tumor marker Biochem Biophys Res Commun 306 2003 16 25
22. Y. Koga, A. Matsuzaki, and A. Suminoe Long-term survival after autologous peripheral blood stem cell transplantation in two patients with malignant rhabdoid tumor of the kidney Pediatr Blood Cancer 52 2009 888 890
23. S. Ning, C. Bin, and H. Na Glypican-3, a novel prognostic marker of hepatocellular cancer, is related with postoperative metastasis and recurrence in hepatocellular cancer patients Mol Biol Rep 39 2012 351 357
24. H. Shirakawa, T. Kuronuma, and Y. Nishimura Glypican-3 is a useful diagnostic marker for a component of hepatocellular carcinoma in human liver cancer Int J Oncol 34 2009 649 656
25. H. Shirakawa, H. Suzuki, and M. Shimomura Glypican-3 expression is correlated with poor prognosis in hepatocellular carcinoma Cancer Sci 100 2009 1403 1407
26. K. Yorita, N. Takahashi, and H. Takai Prognostic significance of circumferential cell surface immunoreactivity of glypican-3 in hepatocellular carcinoma Liver Int 31 2011 120 131